Wealthfront Advisers LLC Increases Stock Position in Intuitive Surgical, Inc. $ISRG

Wealthfront Advisers LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 46,167 shares of the medical equipment provider’s stock after buying an additional 1,481 shares during the period. Wealthfront Advisers LLC’s holdings in Intuitive Surgical were worth $25,088,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Chilton Capital Management LLC increased its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at about $26,000. LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth about $30,000. TD Capital Management LLC increased its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares in the last quarter. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the sale, the director owned 1,074 shares in the company, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 40,724 shares of company stock valued at $19,500,332 in the last three months. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $546.51 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a market capitalization of $195.91 billion, a price-to-earnings ratio of 72.29, a price-to-earnings-growth ratio of 5.45 and a beta of 1.61. The firm’s fifty day moving average price is $458.09 and its 200 day moving average price is $497.29.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period last year, the firm earned $1.84 earnings per share. The company’s revenue was up 22.9% on a year-over-year basis. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on ISRG shares. Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a research note on Wednesday. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Daiwa Capital Markets raised their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday. Finally, Truist Financial set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $602.32.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.